Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

Gro Askgaard; Anton Pottegård; Anders Fink-Jensen

Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

Gro Askgaard, Anton Pottegård, Anders Fink-Jensen

Institut for Klinisk Medicin

Abstract

In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

Bidragets oversatte titel	Benzodiazepines should still be first-line treatment for alcohol withdrawal
Originalsprog	Dansk
Artikelnummer	V07160465
Tidsskrift	Ugeskrift for Laeger
Vol/bind	179
Udgave nummer	3
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 2017

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/benzodiazepiner-er-fortsat-foerstevalg-til-behandling-af-alkoholabstinenssymptomer

Citationsformater

@article{eb4ea27012c4420ab63350dd2c1cb5ef,

title = "Benzodiazepiner er fortsat f{\o}rstevalg til behandling af alkoholabstinenssymptomer",

abstract = "In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.",

author = "Gro Askgaard and Anton Potteg{\aa}rd and Anders Fink-Jensen",

year = "2017",

language = "Dansk",

volume = "179",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "3",

}

TY - JOUR

T1 - Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

AU - Askgaard, Gro

AU - Pottegård, Anton

AU - Fink-Jensen, Anders

PY - 2017

Y1 - 2017

N2 - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

AB - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

M3 - Tidsskriftartikel

C2 - 28115043

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 3

M1 - V07160465

ER -

Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater